Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich

STATESVILLE, N.C., March 3, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company will attend the 2026 analytica tradeshow and conference, taking place in Munich from March 24-27.

Kewaunee will be joined by the Company's recently acquired subsidiary, Nu Aire, Inc. (NuAire), a proven leader in containment and biosafety technologies. Together, they will showcase a complete and complementary portfolio of laboratory infrastructure and safety-focused solutions designed to support the needs of modern lab environments worldwide.

Established in 1968, analytica is the leading global trade fair for laboratory, technology, analysis, and biotechnology. The 2026 trade show and conference is expected to bring together over 30,000 lab professionals, planners, and industry leaders to explore advances in lab innovation, performance, and sustainability.

Kewaunee and NuAire will be joined at the event by ibs tecnomara, a trusted channel partner serving the European market. Together, the three organizations will highlight how coordinated infrastructure and containment solutions, local insight, and over two centuries of combined expertise can help laboratory environments advance performance, safety, and efficiency without compromise.

"Kewaunee's attendance at analytica 2026 represents an important opportunity to connect with global laboratory users, planners, and partners," said Thomas D. Hull III, President and CEO of Kewaunee Scientific Corporation. "Joining with NuAire and ibs tecnomara, we are excited to demonstrate the strength of our integrated solutions and our commitment to supporting amazing laboratory spaces throughout their full project lifecycle."

Kewaunee, NuAire, and ibs tecnomara invite attendees to visit Booth B1.110 during the event to explore:

• Kewaunee's full suite of laboratory solutions, including adaptable bench systems, high-quality steel and wood casework, and energy-efficient fume hoods designed for performance.
• NuAire's containment technologies, including Class II biosafety cabinets and controlled environment systems that meet global safety standards.
• ibs tecnomara's local expertise, supporting European lab planners, end users, and builders with on-the-ground insights and knowledge.

Throughout the week, team members from all three organizations will be available at Booth B1.110 to meet with attendees and provide additional insight into the solutions on display.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville, serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India, serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, Inc. (NuAire), is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, NuAire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.  

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the NuAire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-and-nu-aire-inc-to-attend-analytica-2026-in-munich-302702766.html

SOURCE Kewaunee Scientific Corporation